The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease

1. Swaminathan S, Leung N, Lager D et al. Changing incidence of glomerular disease in Olmsted county, Minnesota: a 30-year biopsy study. Clin J Am Soc Nephrol 2006; 1: 483–487 2. Kitiyakara C, Eggers P, Kopp JB. Twenty-one year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004; 44: 815–825 3. Mitwalli AH, Al Wakeel JS, Al Mohaya SS et al. Pattern of glomerular disease in Saudi Arabia. Am J Kidney Dis 1996; 27: 797–802 4. El-Reshaid W, El-Reshaid K, Kapoor MM et al. Glomerulopathy in Kuwait: the spectrum over the past 7 years. Ren Fail 2003; 25: 619– 630 5. Yahya TM, Pingle A, Boobes Y et al. Data from the United Arab Emirates renal diseases registry. J Nephrol 1998; 11: 148–150 6. Naini A, Harandi A, Ossareh S et al. Prevalence and clinical findings of biopsy proven glomerulonephritis in Iran Saudi J Kidney Dis Transplant 2007; 18: 556–564